Standard BioTools Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	-74.66	-190.1	-59.24	-53.02	-64.79	-59.01	-60.54	-75.99	-53.32	-52.83	Upgrade
Depreciation & Amortization	3.98	3.5	3.65	6.03	4.09	5.37	7.41	6.74	4.92	4.06	Upgrade
Share-Based Compensation	13.12	14.88	16.1	14.45	11.39	11.02	9.09	13.86	16.83	23.59	Upgrade
Other Operating Activities	14.27	82.35	-4.58	17.12	14.1	17.42	19.94	16.25	-3.16	2.56	Upgrade
Operating Cash Flow	-43.29	-89.37	-44.06	-15.42	-35.21	-25.2	-24.1	-39.14	-34.73	-22.62	Upgrade
Capital Expenditures	-2.83	-3.83	-13.26	-12.72	-2.53	-0.37	-1.57	-5.07	-3.98	-7.4	Upgrade
Acquisitions	0	0	1.32	15.88	0	0	0	2.33	0	-112.86	Upgrade
Change in Investments	23.07	-84.3	0	36.81	-36.77	5.09	19.27	47.84	36.4	-58.12	Upgrade
Other Investing Activities	-	-	-	-	-	-	-0.05	-	-6.67	-	Upgrade
Investing Cash Flow	20.24	-88.13	-11.95	39.98	-39.3	4.72	17.66	45.1	25.74	-178.39	Upgrade
Share Issuance / Repurchase	-4.59	0.35	1.49	22	2.13	60.88	29.12	0.23	5.49	5.11	Upgrade
Debt Issued / Paid	-2.08	18.16	16.34	0	3.17	0	0	0	0	195.21	Upgrade
Other Financing Activities	-0.14	212.24	-1.87	-1.14	-2.52	-3.22	-0.12	-0.11	-0.15	-	Upgrade
Financing Cash Flow	-6.81	230.76	15.96	20.86	2.79	57.66	29	0.12	5.34	200.33	Upgrade
Exchange Rate Effect	0.03	-0.4	-0.02	0.39	0.06	0.17	0.45	-0.15	-0.95	-0.87	Upgrade
Net Cash Flow	-29.83	52.86	-40.07	45.8	-71.67	37.35	23.01	5.93	-4.6	-1.55	Upgrade
Free Cash Flow	-46.12	-93.2	-57.33	-28.13	-37.74	-25.57	-25.66	-44.2	-38.72	-30.03	Upgrade
Free Cash Flow Margin	-43.37%	-95.15%	-43.90%	-20.37%	-32.19%	-22.64%	-25.18%	-42.32%	-33.75%	-25.78%	Upgrade
Free Cash Flow Per Share	-0.58	-1.19	-0.76	-0.39	-0.56	-0.65	-0.78	-1.52	-1.35	-1.08	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).